Incidence of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients (pts) with a germline (g) <i>BRCA</i> mutation (m) and platinum-sensitive relapsed ovarian cancer (PSR OC) receiving maintenance olaparib in SOLO2: Impact of prior lines of platinum therapy.

Jacob Korach, Éric Pujade-Lauraine, Tsveta Milenkova et al.|Journal of Clinical Oncology|2018

Cited by 17